# Droxidopa

NDC: 70771-1609
Generic name: Droxidopa
Labeler / Manufacturer: Zydus Lifesciences Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20210219

FDA application: ANDA211818

## Active ingredients

- DROXIDOPA: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70771-1609"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70771-1609
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e9894e44-99ff-471a-bcc2-bfecd55a6559